How to Identify & Manage Patients with Progressive-Fibrosing ILD

CME
30/09/2019 11 min

Listen "How to Identify & Manage Patients with Progressive-Fibrosing ILD "

Descargar episodio Ver en sitio original

Episode Synopsis



Host: Shira Johnson, MD

Guest: Amy L. Olson, MD, MSPH

Guest: Jeffrey Swigris, DO, MS

Guest: Katherine Rosen, RN, MSN, ANP-C



Please note: This activity is no longer available for continuing education credit. This discussion highlights the challenges associated with progressive-fibrosing ILD diagnosis, explains management differences for connective tissue disease-associated ILD, and reviews therapeutic options for the management of PF-ILD.

More episodes of the podcast CME

When Topicals Fail: The New IPC Consensus Every Clinician Should Know 22/12/2025
Engaging Your Patient: Shared Decision-Making in HF With LVEF ≥40% 18/11/2025
The Fifth Pillar? Closing the Gap in HFrEF 14/11/2025
Navigating the Therapeutic Landscape of Platinum-Resistant Ovarian Cancer 14/11/2025
MOA: CDH6-Targeted Antibody-Drug Conjugates 14/11/2025
Clinical Evidence: Insights From Early Trials of CDH6-Targeted Therapies 14/11/2025
Safety and Tolerability of CDH6-Directed Antibody-Drug Conjugates 14/11/2025
Looking Ahead: Integrating CDH6-Targeted Therapies Into Ovarian Cancer Treatment Paradigms 14/11/2025
Treating MASH With Compensated Cirrhosis: A Serious Unmet Need 11/11/2025
Advancing Clinical Expertise in CELMoDs: Transforming Multiple Myeloma Treatment 10/11/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA